Lithium diisopropylamide (LDA)-mediated α- and β-eliminations of epoxides are described. A comparison between LDA/ n -BuOMe mixtures and LDA/MeOCH 2 CH 2 NMe 2 (LDA/ 3 ) mixtures reveals that the LDA dimer solvated by the “hemi-labile” amino ether 3 imparts dramatic rate accelerations, alters relative efficacies of monomer- and dimer-based metalations, and influences the partitioning between α- and β-metalation. The α-elimination of exo -norbornene oxide by LDA/ n -BuOMe and LDA/ 3 proceeds exclusively via a dimer-based pathway with a transition structure, [(R 2 NLi) 2 (epoxide)(ligand)] ⧧ . The β-elimination of tetramethylethylene oxide by LDA/ n -BuOMe and LDA/ 3 proceeds exclusively via a monomer-based pathway with a transition structure, [(R 2 NLi)(epoxide)(ligand)] ⧧ . cis -Cyclooctene epoxide reacts with LDA/ 3 to give two products: (1) a bicyclooctanol derived from an α-metalation and a dimer-based transition structure, [(R 2 NLi) 2 (epoxide)(ligand)] ⧧, and (2) 2-cycloocten-1-ol derived from both a monomer-based transition structure, [(R 2 NLi)(epoxide)(ligand)] ⧧, and a dimer-based transition structure, [(R 2 NLi) 2 (epoxide)(ligand)] ⧧ . Possible geometries of the transition structures are discussed. Hemi-labile ligands that chelate lithium only at the rate-limiting transition structures maximize both the reaction rates and the mechanistic transparency.
No takes yet. Share an insight, caveat, or question.
Ramı́rez et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: